Cabaletta Bio, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Cabaletta Bio, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 9, 2026, to elect directors, ratify auditors, and vote on key corporate actions including a significant increase in authorized shares.
NASDAQ
Cabaletta Bio is holding its 2025 Annual Meeting of Stockholders on June 9, 2025, to vote on key proposals including director elections and increasing authorized shares.
NASDAQ
Cabaletta Bio, Inc. will hold its annual stockholders meeting on June 3, 2024, to elect directors and ratify the appointment of Ernst & Young LLP as its independent accounting firm.
NASDAQ
Cabaletta Bio announces its 2024 Annual Meeting of Stockholders to be held virtually on June 3, 2024, featuring proposals for director elections and ratification of the company's independent auditor.